Heqet Therapeutics
Heqet Therapeutics Heqet Therapeutics develops first-in-class non-coding RNA-based compounds to address highly unmet medical needs in acute myocardial infarction and other cardiovascular diseases. A disruptive approach, to the heart of the disease Heqet Therapeutics is a pre-clinical stage biotech company developing non-coding RNA-based therapies for cardiovascular diseases, with a particular emphasis on acute myocardial infarction. The […]
Private Company
Funding information not available
About
Heqet Therapeutics Heqet Therapeutics develops first-in-class non-coding RNA-based compounds to address highly unmet medical needs in acute myocardial infarction and other cardiovascular diseases. A disruptive approach, to the heart of the disease Heqet Therapeutics is a pre-clinical stage biotech company developing non-coding RNA-based therapies for cardiovascular diseases, with a particular emphasis on acute myocardial infarction. The […]